Although Portugal boasts one of the world's most liberal policies on
drugs and has legal marijuana plantations destined for export, it
has trailed several EU countries such as Italy and Germany, as well
as Canada and parts of the United States in the last few years on
medical marijuana.
Several EU countries allow for doctor-prescribed cannabis-based
medicines to be legally acquired to treat chronic pain, post
traumatic stress disorder, alleviate side effects from cancer
therapy, and help with some other ailments.
Miguel Guimaraes, the head of the Doctor's Association, told Reuters
that he advocated legalizing marijuana-derived medicines based on
scientific evidence, but criticized the part of the draft law that
would permit domestic growing of the plant.
The bill's sponsor, the Left Bloc party, agreed to change the part
of the draft legislation dealing with cultivation at home, saying it
was prepared to make concessions to have "a workable legislation
that would benefit patients".
The move by the far left party makes more likely the passage of a
law legalizing medication derived from the plant, with support from
the country's ruling Socialists and other parties.
Guimaraes said "the parliament bills should follow scientific
evidence and restrict themselves at this stage to medicines,
researched formulas", adding though that Portugal should conduct
further clinical studies on cannabis used for smoking.
"Portugal can have an excellent opportunity here for clinical trials
since we already have two instances where plantations have been
authorized ... It is an extremely promising area at an international
level," he said.
The Left Bloc had argued that the situation with Portugal exporting
legal marijuana while its own patients were unable to buy it legally
was unnatural and hypocritical.
[to top of second column] |
Portugal led the world when it decriminalized the use of all drugs
in 2001 to fight a deadly heroin addiction epidemic, focusing
instead on treatment and prevention, a move that has been lauded at
home and abroad as a success as it sharply reduced deaths and HIV
infections.
Last year, pharmaceuticals regulator INFARMED authorized a medical
marijuana plantation in Cantanhede in central Portugal with a high
content of psychoactive ingredient THC for export.
In November the project's Canadian owner Tilray imported the first
baby plants which are now being grown there, mostly targeting the
German market, according to its CEO Brendan Kennedy. Tilray
estimates the EU's potential market at 30-40 billion euros on an
annual basis, serving 10 million patients.
Portugal on the Atlantic coast has a warm temperate subtropical
climate, with mild winters, warm summers and lots of sunny days,
which is often compared to that of California and makes it an ideal
place for cannabis cultivation.
(Reporting By Andrei Khalip, Editing by William Maclean)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |